PTAB To Review 3 Herceptin Patents In Hospira Challenge
The Patent Trial and Appeal Board agreed Thursday to review three Genentech Inc. patents covering the mega-blockbuster breast cancer drug Herceptin, finding Hospira Inc. had shown claims in each were likely...To view the full article, register now.
Already a subscriber? Click here to view full article